# Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

> **NCT00374842** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 300 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluarix™
- **BIOLOGICAL:** GSK1247446A

## Key facts

- **NCT ID:** NCT00374842
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-03
- **Primary completion:** 2006-11-01
- **Final completion:** 2006-11-30
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374842, "Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00374842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*